Changes in BMD T-score from pre-to post-treatment with biosimilar teriparatide: A single-arm, multi-center study

INTRODUCTION: Teriparatide is a recombinant analog of the parathyroid hormone and an anabolic treatment modality for osteoporosis. This study aimed to evaluate the effectiveness of biosimilar teriparatide (CinnoPar®, CinnaGen Co., Iran) in osteoporotic patients after at least one year of treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Soroush, Mohsen G., Kheirandish, Maryam, Soroosh, Soosan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245092/
https://www.ncbi.nlm.nih.gov/pubmed/37293390
http://dx.doi.org/10.1016/j.bonr.2023.101689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245092/
https://www.ncbi.nlm.nih.gov/pubmed/37293390
http://dx.doi.org/10.1016/j.bonr.2023.101689

Ejemplares similares